Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2020 12-31 |
2019 12-31 |
---|---|---|---|---|
Report Filing | 2025-05-15 | 2025-03-31 | 2021-12-16 | 2020-03-30 |
Revenue | 59.6 | 34.64 | 0 | 0 |
Cost of Revenue | 6.34 | 3.68 | 0 | 0 |
Gross Profit | 53.26 | 30.96 | 0 | 0 |
Operating Expenses | 57.87 | 34.1 | 0.661 | 0.168 |
Research & Development | 15.91 | 9.19 | 0 | 0 |
Selling, General and Administrative | 42.91 | 24.91 | 0 | 0 |
Other Operating Expenses | -0.953 | 0 | 0.661 | 0.168 |
Operating Income | -4.62 | -3.14 | -0.661 | -0.168 |
Net Non-Operating Interest | 4.3 | 2.52 | 0.787 | -0.296 |
Interest Income | -0.028 | 0 | 0.787 | 0 |
Interest Expense | -4.33 | -2.52 | 0 | 0.296 |
Equity & Other Income/(Expense) | -5.42 | -5.13 | 0.002 | 0.593 |
Income Before Tax | -5.74 | -5.75 | 0.128 | 0.128 |
Income Tax Expense | 0 | 0 | 0.027 | 0.027 |
Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 |
Net Income | -5.74 | -5.75 | 0.101 | 0.102 |
Depreciation and Amortization | 3.25 | 0 | 0.789 | 0.592 |
EBITDA | -1.37 | -3.14 | 0.128 | 0.424 |
Earnings Per Share (EPS) | -2.73 | -2.3 | 0.006 | 0.006 |
Diluted Earnings Per Share | -3.64 | -2.3 | 0.006 | 0.006 |
Weighted Average Shares Outstanding | 3.03 | 2.5 | 16.37 | 16.57 |
Diluted Weighted Average Shares Outstanding | 3.03 | 2.5 | 16.37 | 16.57 |